EUGENIE S KLEINERMAN to Protein Kinase Inhibitors
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Protein Kinase Inhibitors.
Connection Strength
0.040
-
Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Cancer. 2010 Aug 15; 116(16):3892-902.
Score: 0.030
-
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. Anticancer Res. 2014 Apr; 34(4):1939-45.
Score: 0.010